{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T04:11:33Z","timestamp":1712031093945},"reference-count":94,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1586\/eem.10.81","type":"journal-article","created":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T14:19:10Z","timestamp":1292595550000},"page":"49-62","source":"Crossref","is-referenced-by-count":5,"title":["Management of neuroendocrine tumors: current and future therapies"],"prefix":"10.1586","volume":"6","author":[{"given":"Kjell E","family":"\u00d6berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"Yao","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23883","volume":"113","author":"Hauso","year":"2008","journal-title":"Cancer"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.sla.0000129342.67174.67","volume":"240","author":"Maggard","year":"2004","journal-title":"Ann. Surg."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11105"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1136\/gut.2004.053314","volume":"54","author":"Ramage","year":"2005","journal-title":"Gut"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1515\/CCLM.1998.147","volume":"36","author":"Pirker","year":"1998","journal-title":"Clin. Chem. Lab. Med."},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000162876","volume":"89","author":"Korse","year":"2009","journal-title":"Neuroendocrinology"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8","volume":"86","author":"Bajetta","year":"1999","journal-title":"Cancer"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2009.24.2669","volume":"28","author":"Yao","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/02841860310010547","volume":"42","author":"Schnirer","year":"2003","journal-title":"Acta Oncol."},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000111034","volume":"87","author":"Eriksson","year":"2008","journal-title":"Neuroendocrinology"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/ERC-08-0017","volume":"15","author":"Pape","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000098012","volume":"84","author":"Falconi","year":"2006","journal-title":"Neuroendocrinology"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0720-048X(00)00187-X","volume":"37","author":"Ricke","year":"2001","journal-title":"Eur. J. Radiol."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.035667"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.beem.2006.12.003","volume":"21","author":"Sundin","year":"2007","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"CIT0018","first-page":"426","volume":"1","author":"Oberndorfer","year":"1907","journal-title":"Frankf. Zschr. Path."},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(63)90951-6","volume":"1","author":"Williams","year":"1963","journal-title":"Lancet"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1196\/annals.1294.002","volume":"1014","author":"Kloppel","year":"2004","journal-title":"Ann. NY Acad. Sci."},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch."},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Arch."},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/er.2003-0014","volume":"25","author":"Kaltsas","year":"2004","journal-title":"Endocr. Rev."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.1999.17.2.600","volume":"17","author":"Rubin","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Beaumont J, Zhimei L, Choi S.et al.Health-related quality of life of patients with neuroendocrine tumor compared to the United States general population. Presented at:2nd Annual Meeting of the North American NeuroEndocrine Tumor Society. Charlotte, North Carolina, USA, 2\u20133 October 2009.","DOI":"10.1097\/01.mpa.0000363909.53692.01"},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9610(05)80529-X","volume":"165","author":"Basson","year":"1993","journal-title":"Am. J. Surg."},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol."},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","volume":"340","author":"Kulke","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000085237","volume":"80","author":"Plockinger","year":"2004","journal-title":"Neuroendocrinology"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"ii104","DOI":"10.1093\/annonc\/mdn117","volume":"19","author":"\u00d6berg","year":"2008","journal-title":"Ann. Oncol."},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.12.008"},{"key":"CIT0032","first-page":"1091","volume":"108","author":"McEntee","year":"1990","journal-title":"Surgery"},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(03)00235-9","volume":"1616","author":"Moller","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/annonc\/mdl105","volume":"17","author":"Susini","year":"2006","journal-title":"Ann. Oncol."},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1159\/000080741"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2007.09.006"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198609113151102"},{"key":"CIT0038","first-page":"1229","volume":"313","author":"Kvols","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01420.x"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.0.1510107","volume":"151","author":"Welin","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2165\/00003495-198938050-00002","volume":"38","author":"Battershill","year":"1989","journal-title":"Drugs"},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM198501033120104","volume":"312","author":"Maton","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000201070","volume":"54","author":"Gyr","year":"1993","journal-title":"Digestion"},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/BF01300194","volume":"32","author":"Dueno","year":"1987","journal-title":"Dig. Dis. Sci."},{"key":"CIT0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000201396","volume":"57","author":"Anthony","year":"1996","journal-title":"Digestion"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1159\/000082875"},{"key":"CIT0047","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2036.2009.04174.x","volume":"31","author":"Modlin","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"CIT0048","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00000421-200008000-00020","volume":"23","author":"Ricci","year":"2000","journal-title":"Am. J. Clin. Oncol."},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.1989.tb00436.x","volume":"30","author":"Wynick","year":"1989","journal-title":"Clin. Endocrinol."},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jcem-73-1-1","volume":"73","author":"Wynick","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CIT0051","first-page":"36","volume":"28","author":"Hofland","year":"2005","journal-title":"J. Endocrinol. Invest."},{"key":"CIT0052","first-page":"P659","volume":"16","author":"van Vugt","year":"2008","journal-title":"Endocrine Abstracts"},{"key":"CIT0053","doi-asserted-by":"crossref","unstructured":"Kvols L, Wiedenmann B, \u00d6berg Ket al.Safety and efficacy of pasireotide (SOM230) in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR: results of a Phase II study. Presented at:ASCO GI Cancers Symposium. San Francisco, CA, USA, 26\u201328 January 2006 (Abstract 171).","DOI":"10.1200\/jco.2006.24.18_suppl.4082"},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1677\/ERC-07-0288","volume":"15","author":"Grozinsky-Glasberg","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.3.430"},{"key":"CIT0056","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/annonc\/mdj113","volume":"17","author":"Panzuto","year":"2006","journal-title":"Ann. Oncol."},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cncr.10195","volume":"94","author":"Shojamanesh","year":"2002","journal-title":"Cancer"},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<402::AID-CNCR25>3.0.CO;2-4","volume":"77","author":"di Bartolomeo","year":"1996","journal-title":"Cancer"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930701)72:1<244::AID-CNCR2820720143>3.0.CO;2-Q"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"Rinke","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0959-8049(01)00073-9","volume":"37","author":"Aparicio","year":"2001","journal-title":"Eur. J. Cancer."},{"key":"CIT0062","first-page":"152","volume":"2","author":"Kulke","year":"2008","journal-title":"Gastrointest. Cancer Res."},{"key":"CIT0063","unstructured":"Pavel M, Heuck F, Plockinger Uet al.Prospective randomized trial: biotherapy versus chemotherapy in malignant nonfunctional neuroendocrine tumors of the pancreas and bronchial tract (ENET-1). Presented at:ASCO GI Cancers Symposium. Orlando, FL, USA, 25\u201327 January 2008 (Abstract 202)."},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.12.142"},{"key":"CIT0065","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.3748\/wjg.v16.i24.2963","volume":"16","author":"Strosberg","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh216"},{"key":"CIT0067","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1542-3565(05)00481-7","volume":"3","author":"Arnold","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4149"},{"key":"CIT0069","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3748\/wjg.v11.i13.2041","volume":"11","author":"Bondanelli","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"CIT0070","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"key":"CIT0071","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1158\/0008-5472.CAN-3554-2","volume":"64","author":"Boulay","year":"2004","journal-title":"Cancer Res."},{"key":"CIT0072","doi-asserted-by":"crossref","first-page":"10570","DOI":"10.1200\/jco.2007.25.18_suppl.10570","volume":"25","author":"Horsch","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"CIT0073","first-page":"3801","volume":"28","author":"Cejka","year":"2008","journal-title":"Anticancer Res."},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.3816\/CBC.2006.n.047"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.7858"},{"key":"CIT0076","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1200\/JCO.2008.20.0766","volume":"27","author":"Meric-Bernstam","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"CIT0077","unstructured":"Pavel M. RADIANT-2 \u2013 No. LBA8. A randomized, double-blind, placebo controlled, multicentre Phase 3 trial of everolimus plus octreotide LAR vs. placebo plus octreotide LAR in patients with advanced neuroendocrine tumors (NET) (RADIANT-2). Presented at:European Society for Medical Oncology. Milan, Italy, 8\u201312 October 2010."},{"key":"CIT0078","doi-asserted-by":"crossref","unstructured":"Raymond E, Niccoli P, Raoul Jet al.Cox proportional hazard analysis of sunitinib (SU) efficacy across subgroups of patients (pts) with progressive pancreatic neuroendocrine tumors (NET). Presented at:ASCO Annual Meeting. Chicago, IL, USA, 4\u20138 June 2010 (Abstract 4031).","DOI":"10.1200\/jco.2010.28.15_suppl.4031"},{"key":"CIT0079","unstructured":"Yao J. RADIANT-3 \u2013 No. LBA9. A randomized, double-blind, placebo controlled, multicentre phase 3 trial of everolimus in patients with advanced pancreatic NETs. Presented at:European Society for Medical Oncology. Milan, Italy, 8\u201312 October 2010."},{"key":"CIT0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.1983.1.11.727","volume":"1","author":"Moertel","year":"1983","journal-title":"J. Clin. Oncol."},{"key":"CIT0081","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.annonc.a058291","volume":"3","author":"Janson","year":"1992","journal-title":"Ann. Oncol."},{"key":"CIT0082","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/bjc.1992.372","volume":"66","author":"Biesma","year":"1992","journal-title":"Br. J. Cancer"},{"key":"CIT0083","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1530\/eje.0.1410590","volume":"141","author":"Turner","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2053"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.6046"},{"key":"CIT0086","volume-title":"Cancer","author":"Strosberg","year":"2010"},{"key":"CIT0087","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.beem.2007.01.007","volume":"21","author":"Forrer","year":"2007","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"CIT0088","first-page":"301","volume":"26","author":"Comaru-Schally","year":"2005","journal-title":"Int. J. Cancer"},{"key":"CIT0089","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.semnuclmed.2006.01.001","volume":"6","author":"Valkema","year":"2006","journal-title":"Semin. Nucl. Med. 3"},{"key":"CIT0090","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1200\/JCO.2007.15.2553","volume":"26","author":"Kwekkeboom","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"CIT0091","unstructured":"Wolin E, Kvols L, Ezzat Set al.Pasireotide LAR in patients with metastatic carcinoid tumors: pharmacokinetics (PK) and safety results from a randomized, multicenter, Phase I study. Presented at:ASCO GI Cancers Symposium. San Francisco, CA, USA, 15\u201317 Januray 2009 (Abstract 93)."},{"key":"CIT0092","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1677\/JME-08-0012","volume":"40","author":"Pasquali","year":"2008","journal-title":"J. Mol. Endocrinol."},{"key":"CIT0093","unstructured":"Pavel M, Hassler G, Schmid HA, van Vugt HH, Hahn EG, Schuppan DS. Pasireotide strongly inhibits migration and proliferation of human micro- and macrovascular endothelial cells mainly via somatostatin receptor subtype 5 and FAK, ERK1\/2 and p38 pathways.ENDOAbstract 1, P2\u2013352 (2006)."},{"key":"CIT0094","first-page":"113","volume":"2","author":"Strosberg","year":"2008","journal-title":"Gastrointest. Cancer Res."}],"container-title":["Expert Review of Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/eem.10.81","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T03:56:41Z","timestamp":1712030201000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/eem.10.81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1586\/eem.10.81"],"URL":"https:\/\/doi.org\/10.1586\/eem.10.81","relation":{},"ISSN":["1744-6651","1744-8417"],"issn-type":[{"value":"1744-6651","type":"print"},{"value":"1744-8417","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}